Article Details

Disc Medicine nabs $90M for blood disease pipeline, new Roche asset | FierceBiotech

Retrieved on: 2021-09-02 11:37:30

Tags for this article:

Click the tags to see associated articles and topics

Disc Medicine nabs $90M for blood disease pipeline, new Roche asset | FierceBiotech. View article details on hiswai:

Excerpt

Disc recently licensed the drug from Roche, which had been testing the drug predominately in psychiatric disorders such as schizophrenia, but results were ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up